Cargando…
The infantile neuroaxonal dystrophy rating scale (INAD-RS)
BACKGROUND: INAD is an autosomal recessive neurogenetic disorder caused by biallelic pathogenic variants in PLA2G6. The downstream enzyme, iPLA(2), plays a critical role in cell membrane homeostasis by helping to regulate levels of phospholipids. The clinical presentation occurs between 6 months and...
Autores principales: | Atwal, Paldeep S., Midei, Mark, Adams, Darius, Fay, Alexander, Heerinckx, Frederic, Milner, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392694/ https://www.ncbi.nlm.nih.gov/pubmed/32727524 http://dx.doi.org/10.1186/s13023-020-01479-5 |
Ejemplares similares
-
Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases
por: Adams, Darius, et al.
Publicado: (2020) -
The natural history of infantile neuroaxonal dystrophy
por: Altuame, Fadie D., et al.
Publicado: (2020) -
Exploring therapeutic strategies for infantile neuronal axonal dystrophy (INAD/PARK14)
por: Lin, Guang, et al.
Publicado: (2023) -
Infantile Neuroaxonal Dystrophy: Diagnosis and Possible Treatments
por: Babin, Patricia L., et al.
Publicado: (2018) -
RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations
por: Angelova, Plamena R., et al.
Publicado: (2021)